Network origin in Christian Zahnd first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christian Zahnd via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Zurich | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chairman | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California San Diego | College/University | Doctorate Degree Doctorate Degree | |
| MORPHOSYS AG | Biotechnology | Founder Corporate Officer/Principal | |
| Imperial College London | College/University | Corporate Officer/Principal Undergraduate Degree | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
| Pfizer International LLC | Chief Tech/Sci/R&D Officer | ||
| RAND Health | Director/Board Member | ||
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Director/Board Member | |
| GENVEC INC | Pharmaceuticals: Major | Director/Board Member | |
The International Centre for Missing & Exploited Children
 The International Centre for Missing & Exploited Children Services to the Health IndustryHealth Services The International Centre for Missing & Exploited Children is an organization that focuses on finding missing children and protecting children from exploitation worldwide. The non-profit company is based in Alexandria, VA and the CEO of the company is Paul Shapiro. The company's work involves powering the search for missing children and implementing measures to safeguard children from harm. | Services to the Health Industry | Director/Board Member | |
CardioRhythm
 CardioRhythm Medical SpecialtiesHealth Technology Part of Medtronic Plc, CardioRhythm is a company that manufactures electrophysiological catheters. The company is based in San Jose, CA. CardioRhythm was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on May 26, 1992. | Medical Specialties | Director/Board Member | |
Sierra Ventures Management LLC
 Sierra Ventures Management LLC Investment ManagersFinance Sierra Ventures, Inc (Sierra Ventures) is a venture capital firm founded in 1982 by Peter Wendell. The firm is headquartered in San Mateo, California. | Investment Managers | Corporate Officer/Principal | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director/Board Member | |
White Pine Medical, Inc.
 White Pine Medical, Inc. Medical SpecialtiesHealth Technology White Pine Medical, Inc. manufactures and markets medical devices. The company was founded in February 2010 and is headquartered in Park City, UT. | Medical Specialties | Director/Board Member | |
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Bristol-Myers Squibb Pharma Research Labs LLC researches and develops drugs and related pharmaceutical products. The company is headquartered in San Diego, CA | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Astra Research Centre AB | Chairman | ||
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Chairman | |
| NANEXA AB | Medical Specialties | Chairman | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member | |
| Pfizer AB | Chief Tech/Sci/R&D Officer | ||
IPVALUE Management, Inc.
 IPVALUE Management, Inc. Miscellaneous Commercial ServicesCommercial Services IPVALUE Management, Inc. provides strategic intellectual property consultation services. It specializes in IP rights licensing, technology transfer and enablement, spin-outs, and new venture formation. The company was founded by Peter Wheeler and Joseph J. Cote in 2001 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Helsinki | College/University | Doctorate Degree | |
| Stanford University | College/University | Masters Business Admin | |
| Nouscom Srl | Miscellaneous Commercial Services | Chairman | |
EDB Investments Pte Ltd.
 EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | Investment Managers | Consultant / Advisor | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal |
Statistics
International
| United States | 26 |
| United Kingdom | 9 |
| Switzerland | 7 |
| Sweden | 4 |
| Denmark | 3 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 76 |
| Corporate Officer/Principal | 38 |
| Chairman | 24 |
| Chief Tech/Sci/R&D Officer | 19 |
| Founder | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Steven Holtzman | 28 |
| Petri T. Vainio | 24 |
| Jeffrey H. Buchalter | 15 |
| Jörn Aldag | 15 |
| Andreas Emmenegger | 14 |
| Lisa Rojkjaer | 12 |
| William Lee | 8 |
| Michael Tobias Stumpp | 7 |
| Andreas Plückthun | 7 |
| Andreas Harstrick | 7 |
| Julien Gander | 6 |
| Patrick Amstutz | 5 |
| Daniel Steiner | 4 |
| Patrik Forrer | 3 |
- Stock Market
- Insiders
- Christian Zahnd
- Company connections
